Abstract
To evaluate the association of obesity with Gleason scores determined in biopsy and radical prostatectomy specimens. Cohort study. Urology Department, Fatih Sultan Mehmet Research Hospital, Istanbul, Turkey from 2007 to 2015. A total of 111 patients, younger than 65 years who underwent radical prostatectomy (RP) with the diagnosis of prostate cancer, were included in the study. Histopathology reports of the surgical, and TRUS-guided prostate biopsy specimens were analysed. Body mass index (BMI) and prostate specific antigen (PSA) levels were also evaluated. Mean age of the patients was 59.06 ±4.10 (range = 47-64 years) years. Mean BMI of the patients was 25.59 ±3.24 kg/m2 (range = 19-35 kg/m2). In patients whose BMI measurements were equal or above 25 kg/m2; a significant difference was found between Gleason scores of the needle biopsy and RP specimens (p=0.001). BMI and PSA, which are known to be the most important parameters effecting Gleason score, were evaluated in combination. Regarding non-concordance with Gleason scores, it has been observed that as a predisposing factor, obesity can explain these incompatibilities similarly to PSA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
